Latest Institutional Placement News

Manuka Resources has secured A$14.5 million through a placement to fund finishing its silver de-slime circuit and accelerate production at Wonawinta, targeting first gold sales by September and silver revenues from January 2027.

Brightstar Resources has secured over A$380 million in funding to fully finance its Goldfields Project, commencing construction of a 1.5Mtpa Laverton processing plant with first gold targeted mid-2027, while expanding its Sandstone resource base to 2.9Moz.

FireFly Metals has raised approximately A$180 million through a dual-market equity raising to accelerate development of its Green Bay Copper-Gold Project in Newfoundland, Canada.

Maronan Metals has marked a transformative year with a positive Preliminary Economic Assessment, grant of a key Mineral Development Licence, and two capital raises totaling nearly A$40 million, positioning the company for accelerated development of its Queensland silver-lead and copper-gold project.

EcoGraf Limited (ASX:EGR) is raising approximately AUD 2 million through an underwritten Share Purchase Plan (SPP) offering new shares at a 20% discount. The funds will support key project financing and expansion activities at its Epanko Graphite Project and related operations.

Titomic has raised A$16.5 million through an institutional placement priced at a 23.5% discount, aiming to scale its Huntsville facility and accelerate US growth. The company also advanced a US$10 million loan application with the Export-Import Bank and appointed aerospace veteran Jim Chilton to its board.

Alliance Aviation Services has launched the retail tranche of its fully underwritten $40 million equity raising, offering shareholders new shares at $0.70 each to reinforce its balance sheet and support ongoing turnaround efforts.

GR Engineering Services launches a $10 million share purchase plan at the same price as a recent $100 million institutional placement, offering eligible shareholders a chance to invest up to $30,000 each.

Percheron Therapeutics has raised $2.3 million through an institutional placement to fully fund its upcoming acute myeloid leukemia clinical trial led by Vanderbilt Health.

Recce Pharmaceuticals narrowed its operating loss to AUD 15 million in FY26, progressing Phase 3 trials for its anti-infective RECCE 327 and securing key patents and commercial partnerships.

NOVONIX Limited posted a $24.6 million half-year loss while delivering a critical synthetic graphite sample to Panasonic and reaffirming a 2027 production start. The company raised $21.7 million to fund its North American battery materials expansion amid ongoing U.S. trade and policy developments.

L1 Gold Fund Limited (ASX:LGF) has launched a retail entitlement offer aiming to raise up to $261.7 million by issuing one new share for every three held, priced at $2.25 each. This follows a $254.9 million institutional placement and entitlement offer completed earlier in August.